Early PSA response to antiandrogen therapy in metastatic castration-resistant prostate carcinoma patients: A predictive marker for progression-free survival?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAtakan, Demir
dc.contributor.authorOzkan, Alan
dc.contributor.authorGuven, Mert Aslihan
dc.contributor.authorSinan, Koca
dc.date.accessioned2025-10-16T15:21:33Z
dc.date.issued2020
dc.identifier.otherWOS:000549861700019
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7690
dc.publisherIMPRIMATUR PUBLICATIONS
dc.sourceJOURNAL OF BUON
dc.subjectmetastatic castration\\-resistant prostate cancer
dc.subjectabiraterone acetate
dc.subjectenzalutamide
dc.subjectPSA response
dc.subjectearly PSA response
dc.subjectpredictive biomarker
dc.titleEarly PSA response to antiandrogen therapy in metastatic castration-resistant prostate carcinoma patients: A predictive marker for progression-free survival?
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS